News Hyundai Pharmaceutical Co., Ltd.

Equities

A004310

KR7004310009

End-of-day quote Korea S.E. Other stock markets 03:30:00 10/05/2024 am IST			5-day change	1st Jan Change
3,775 ^KRW	-0.40%		-0.53%	-8.15%

2023	Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.	CI
2023	Hyundai Pharmaceutical Co., Ltd.(KOSE:A004310) dropped from S&P Global BMI Index	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.	16/23/16	CI
Hyundai Pharmaceutical Co., Ltd.(KOSE:A004310) dropped from S&P Global BMI Index	18/23/18	CI
Hyundai Pharmaceutical Co., Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares.	14/23/14	CI
Hyundai Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	14/23/14	CI
Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 23, 2022.	22/23/22	CI
Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 23, 2022.	22/23/22	CI
Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 23, 2022.	22/23/22	CI
Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 23, 2022.	22/23/22	CI
Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 23, 2022.	22/23/22	CI
Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback announced on June 23, 2022, has expired with 968,118 shares, representing 3.50% for KRW 4,388.11 million.	22/23/22	CI
Hyundai Pharmaceutical Co., Ltd. announces an Equity Buyback for KRW 5,000 million worth of its shares.	23/22/23	CI
Hyundai Pharmaceutical Co., Ltd. authorizes a Buyback Plan.	23/22/23	CI
Market Chatter: Hyundai Pharmaceutical Seeks Regulatory Approval to Market Abortion Pill in South Korea	07/21/07	MT
Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback announced on July 14, 2008, has expired.	08/21/08	CI
Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback announced on April 22, 2010, has expired.	08/21/08	CI
Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback announced on June 28, 2019, has expired.	08/21/08	CI
Hyundai Pharmaceutical Co., Ltd.(KOSE:A004310) added to S&P Global BMI Index	21/20/21	CI
Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan Extended till June 25, 2021.	26/20/26	CI
Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan Extended till April 16, 2021.	14/20/14	CI
Tranche Update on Hyundai Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on June 28, 2019.	27/19/27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Hyundai Pharmaceutical Co., Ltd.

Equities

A004310

KR7004310009

Summary

Filters